$Biorestorative Therapies (BRTX.US)$ BioRestorative Therapie...
$Biorestorative Therapies(BRTX.US$ BioRestorative Therapies (BRTX) said Tuesday that the US Food and Drug Administration has cleared an amendment to the protocol of the current phase 2 trial of its cell therapy candidate, BRTX-100, to treat chronic lumbar disc disease.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment